Darzalex Faspro
RxNorm concept 2375137, brand name (bn).
- RxCUI
- 2375137
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2375137 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- daratumumab-fihj (PIN, has precise ingredient)
- hyaluronidase-fihj (PIN, has precise ingredient)
- daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML [Darzalex Faspro] (SBDC, ingredient of)
- daratumumab / hyaluronidase Injection [Darzalex Faspro] (SBDF, ingredient of)
- Darzalex Faspro Injectable Product (SBDG, ingredient of)
- 15 ML daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection [Darzalex Faspro] (SBD, ingredient of)
- hyaluronidase (IN, tradename of)
- daratumumab (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2375137 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2375137 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2375137. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.